{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 4
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Windsor",
      "state": "CT",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "86193",
      "recalling_firm": "SCA Pharmaceuticals",
      "address_1": "755 Rainbow Rd Ste B",
      "address_2": "N/A",
      "postal_code": "06095-1024",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the U.S.",
      "recall_number": "D-1553-2020",
      "product_description": "Heparin Sodium 10,000 units in 0.9% Sodium Chloride 1000 mL, Single Dose Container, Rx Only Injection for Intravenous Use (10 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0652-46, Bar Code 70004065246.",
      "product_quantity": "362 Containers",
      "reason_for_recall": "Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.",
      "recall_initiation_date": "20200729",
      "center_classification_date": "20200827",
      "termination_date": "20210521",
      "report_date": "20200902",
      "code_info": "Lot #: 1220019457, Exp 08/24/2020"
    }
  ]
}